首页> 外文期刊>Journal of Chromatography, Biomedical Applications >Determination of mirtazapine and its demethyl metabolite in plasma by high-performance liquid chromatography with ultraviolet detection
【24h】

Determination of mirtazapine and its demethyl metabolite in plasma by high-performance liquid chromatography with ultraviolet detection

机译:高效液相色谱-紫外检测法测定血浆中米氮平及其去甲基代谢物

获取原文
获取原文并翻译 | 示例
           

摘要

Mirtazapine is a new centrally acting noradrenergic and specific serotonin antidepressant, with an active demethyl metabolite. For toxicological puroposes, a specific and accurate RP-HPLC assay was developed for the simultaneous plasma determination of these compounds. A liner response was observed over the concentration range 50-500 ng/ml. A good accuracy (bias <10%) was achieved for all quality controls, with intra-day and inter-day variation coefficients less than 8.3%. The lower limit of quantification was 20 ng/ml, without interferences with endogenous or exogenous components. This rapid method (run time <12 min) was used to manage three intoxications involving mirtazapine.
机译:米氮平是一种新型的中枢去甲肾上腺素能和特定的5-羟色胺抗抑郁药,具有活性的去甲基代谢产物。对于毒理学目的,开发了一种特定且准确的RP-HPLC测定法,用于同时测定这些化合物的血浆。在50-500 ng / ml的浓度范围内观察到了衬里响应。所有质量控制均达到了良好的准确性(偏差<10%),日内和日间变异系数均小于8.3%。定量下限为20 ng / ml,不干扰内源或外源成分。该快速方法(运行时间<12分钟)用于处理涉及米氮平的三种中毒事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号